vs
Apellis Pharmaceuticals, Inc.（APLS）与XPLR Infrastructure, LP（XIFR）财务数据对比。点击上方公司名可切换其他公司
XPLR Infrastructure, LP的季度营收约是Apellis Pharmaceuticals, Inc.的1.2倍（$249.0M vs $199.9M），XPLR Infrastructure, LP净利率更高（11.2% vs -29.5%，领先40.7%），Apellis Pharmaceuticals, Inc.同比增速更快（-5.9% vs -15.3%），Apellis Pharmaceuticals, Inc.自由现金流更多（$-14.3M vs $-88.0M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -1.6%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
XPLR Infrastructure, LP是NextEra Energy旗下公开上市的子公司，总部位于佛罗里达州朱诺海滩，是一家专注可再生能源领域的企业。
APLS vs XIFR — 直观对比
营收规模更大
XIFR
是对方的1.2倍
$199.9M
营收增速更快
APLS
高出9.4%
-15.3%
净利率更高
XIFR
高出40.7%
-29.5%
自由现金流更多
APLS
多$73.7M
$-88.0M
两年增速更快
APLS
近两年复合增速
-1.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $249.0M |
| 净利润 | $-59.0M | $28.0M |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | -19.3% |
| 净利率 | -29.5% | 11.2% |
| 营收同比 | -5.9% | -15.3% |
| 净利润同比 | -62.2% | 124.3% |
| 每股收益（稀释后） | $-0.40 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSXIFR
| Q4 25 | $199.9M | $249.0M | ||
| Q3 25 | $458.6M | $315.0M | ||
| Q2 25 | $178.5M | $342.0M | ||
| Q1 25 | $166.8M | $282.0M | ||
| Q4 24 | $212.5M | $294.0M | ||
| Q3 24 | $196.8M | $319.0M | ||
| Q2 24 | $199.7M | $360.0M | ||
| Q1 24 | $172.3M | $257.0M |
净利润APLSXIFR
| Q4 25 | $-59.0M | $28.0M | ||
| Q3 25 | $215.7M | $-37.0M | ||
| Q2 25 | $-42.2M | $79.0M | ||
| Q1 25 | $-92.2M | $-98.0M | ||
| Q4 24 | $-36.4M | $-115.0M | ||
| Q3 24 | $-57.4M | $-40.0M | ||
| Q2 24 | $-37.7M | $62.0M | ||
| Q1 24 | $-66.4M | $70.0M |
营业利润率APLSXIFR
| Q4 25 | -25.6% | -19.3% | ||
| Q3 25 | 48.7% | 1.6% | ||
| Q2 25 | -18.6% | 26.3% | ||
| Q1 25 | -50.0% | -82.6% | ||
| Q4 24 | -12.3% | -188.1% | ||
| Q3 24 | -24.0% | 15.4% | ||
| Q2 24 | -14.7% | 18.3% | ||
| Q1 24 | -36.0% | -8.2% |
净利率APLSXIFR
| Q4 25 | -29.5% | 11.2% | ||
| Q3 25 | 47.0% | -11.7% | ||
| Q2 25 | -23.6% | 23.1% | ||
| Q1 25 | -55.3% | -34.8% | ||
| Q4 24 | -17.1% | -39.1% | ||
| Q3 24 | -29.2% | -12.5% | ||
| Q2 24 | -18.9% | 17.2% | ||
| Q1 24 | -38.5% | 27.2% |
每股收益（稀释后）APLSXIFR
| Q4 25 | $-0.40 | — | ||
| Q3 25 | $1.67 | $-0.40 | ||
| Q2 25 | $-0.33 | $0.84 | ||
| Q1 25 | $-0.74 | $-1.05 | ||
| Q4 24 | $-0.30 | — | ||
| Q3 24 | $-0.46 | $-0.43 | ||
| Q2 24 | $-0.30 | $0.66 | ||
| Q1 24 | $-0.54 | $0.75 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $960.0M |
| 总债务越低越好 | — | $6.2B |
| 股东权益账面价值 | $370.1M | $10.9B |
| 总资产 | $1.1B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.57× |
8季度趋势，按日历期对齐
现金及短期投资APLSXIFR
| Q4 25 | $466.2M | $960.0M | ||
| Q3 25 | $479.2M | $711.0M | ||
| Q2 25 | $370.0M | $880.0M | ||
| Q1 25 | $358.4M | $1.5B | ||
| Q4 24 | $411.3M | $283.0M | ||
| Q3 24 | $396.9M | $290.0M | ||
| Q2 24 | $360.1M | $281.0M | ||
| Q1 24 | $325.9M | $245.0M |
总债务APLSXIFR
| Q4 25 | — | $6.2B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $5.3B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益APLSXIFR
| Q4 25 | $370.1M | $10.9B | ||
| Q3 25 | $401.2M | $11.0B | ||
| Q2 25 | $156.3M | $11.3B | ||
| Q1 25 | $164.2M | $12.6B | ||
| Q4 24 | $228.5M | $12.9B | ||
| Q3 24 | $237.1M | $13.6B | ||
| Q2 24 | $264.3M | $13.9B | ||
| Q1 24 | $266.7M | $14.0B |
总资产APLSXIFR
| Q4 25 | $1.1B | $19.6B | ||
| Q3 25 | $1.1B | $19.1B | ||
| Q2 25 | $821.4M | $20.5B | ||
| Q1 25 | $807.3M | $21.4B | ||
| Q4 24 | $885.1M | $20.3B | ||
| Q3 24 | $901.9M | $20.9B | ||
| Q2 24 | $904.5M | $21.7B | ||
| Q1 24 | $831.9M | $22.3B |
负债/权益比APLSXIFR
| Q4 25 | — | 0.57× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.41× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $186.0M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $-88.0M |
| 自由现金流率自由现金流/营收 | -7.1% | -35.3% |
| 资本支出强度资本支出/营收 | 0.1% | 110.0% |
| 现金转化率经营现金流/净利润 | — | 6.64× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $-219.0M |
8季度趋势，按日历期对齐
经营现金流APLSXIFR
| Q4 25 | $-14.2M | $186.0M | ||
| Q3 25 | $108.5M | $231.0M | ||
| Q2 25 | $4.4M | $232.0M | ||
| Q1 25 | $-53.4M | $90.0M | ||
| Q4 24 | $19.4M | $283.0M | ||
| Q3 24 | $34.1M | $208.0M | ||
| Q2 24 | $-8.3M | $231.0M | ||
| Q1 24 | $-133.0M | $78.0M |
自由现金流APLSXIFR
| Q4 25 | $-14.3M | $-88.0M | ||
| Q3 25 | $108.3M | $-283.0M | ||
| Q2 25 | $4.4M | $151.0M | ||
| Q1 25 | $-53.4M | $1.0M | ||
| Q4 24 | $19.3M | $231.0M | ||
| Q3 24 | — | $152.0M | ||
| Q2 24 | $-8.4M | $162.0M | ||
| Q1 24 | $-133.3M | $14.0M |
自由现金流率APLSXIFR
| Q4 25 | -7.1% | -35.3% | ||
| Q3 25 | 23.6% | -89.8% | ||
| Q2 25 | 2.5% | 44.2% | ||
| Q1 25 | -32.0% | 0.4% | ||
| Q4 24 | 9.1% | 78.6% | ||
| Q3 24 | — | 47.6% | ||
| Q2 24 | -4.2% | 45.0% | ||
| Q1 24 | -77.3% | 5.4% |
资本支出强度APLSXIFR
| Q4 25 | 0.1% | 110.0% | ||
| Q3 25 | 0.0% | 163.2% | ||
| Q2 25 | 0.0% | 23.7% | ||
| Q1 25 | 0.0% | 31.6% | ||
| Q4 24 | 0.0% | 17.7% | ||
| Q3 24 | 0.0% | 17.6% | ||
| Q2 24 | 0.0% | 19.2% | ||
| Q1 24 | 0.2% | 24.9% |
现金转化率APLSXIFR
| Q4 25 | — | 6.64× | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | 2.94× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.73× | ||
| Q1 24 | — | 1.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
XIFR
| Renewable Energy Sales | $238.0M | 96% |
| Related Party | $8.0M | 3% |
